Impressive regression of visceral and cerebral melanoma metastases under combination treatment including dacarbacine, radiotherapy and celecoxib.
Becker
Maria Rita
MR
Gaiser
Timo
T
D000293:Adolescent; D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy / Q000556:secondary; D000068579:Celecoxib; D003131:Combined Modality Therapy; D016861:Cyclooxygenase Inhibitors / Q000627:therapeutic use; D003606:Dacarbazine / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008545:Melanoma / Q000188:drug therapy* / Q000532:radiotherapy / Q000556:secondary; D011720:Pyrazoles / Q000627:therapeutic use*; D012878:Skin Neoplasms / Q000473:pathology*; D013449:Sulfonamides / Q000627:therapeutic use*; D014062:Tongue Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000556:secondary
D018906:Antineoplastic Agents, Alkylating; D016861:Cyclooxygenase Inhibitors; D011720:Pyrazoles; D013449:Sulfonamides; D003606:Dacarbazine; D000068579:Celecoxib